Accueil   Diary - News   All news ENYO Pharma announces closing of a €22 million funding round

ENYO Pharma announces closing of a €22 million funding round

ENYO Pharma, a biopharmaceutical company focused on developing treatments for acute and chronic viral infections, today announced that it has secured a €22 million Series A financing round. The investment is intended to help the company roll out its clinical hepatitis-B programme more quickly.

 

 

Read the press release